Free press releases distribution network?

Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Time Saving Benefits of Biochips Propels their Demand in the U.S. Biochips Markets - New analysis from Frost and Sullivan - Owing to their ability to considerably reduce assay time—biochip technologies, including DNA microarrays, proteomics arrays, and microfluidics systems, are witnessing healthy demand
Time Saving Benefits of Biochips Propels their Demand in the U.S. Biochips Markets

 

PRZOOM - /newswire/ - San Antonio, TX, United States, 2007/02/27 - New analysis from Frost and Sullivan - Owing to their ability to considerably reduce assay time—biochip technologies, including DNA microarrays, proteomics arrays, and microfluidics systems, are witnessing healthy demand.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

New analysis from Frost and Sullivan Strategic Analysis of U.S. Biochips Markets, reveals that U.S.-based sales of biochip technologies generated revenues of $582.7 million in 2005, and are likely to reach $1.47 billion in 2012.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants an overview of the latest analysis of the Strategic Analysis of U.S. Biochips Markets, then send an e-mail to Melina Trevino - Corporate Communications with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information via email upon receipt of the above information.

Scientists often spend hours of manual time in preparation for an experiment and expend several hours waiting for the completion of the same. Biochip technologies, applied to experiments that involve nucleic acids, have greatly reduced the time taken for hybridization.

“With biochip technologies, laboratories not only save time and decrease long-term costs and sample size, but they also increase productivity, reproducibility, and improve efficiency,” notes Frost & Sullivan Industry Analyst, Jonathan Witonsky. “This can greatly increase the growth potential of the biochips markets.”

With increasing proteomics array technology sales likely to be a major contributor, the future holds good for the U.S. biochips markets. Proteomics array technology sales expect to grow at double the rate of any other U.S. biochips market segment, while the microfluidics/lab-on-a-chip markets expect to match the growth rate of the total U.S. biochips market.

“DNA microarray technologies are currently at the cusp of the molecular diagnostics revolution and present numerous market opportunities,” cites Witonsky. “This segment is likely to contribute the most revenue toward the total U.S. biochips markets through 2012.”

However, the recent spur of investment in alternative laboratory automation is limiting the market demand for multiple biochip-based devices. Many of the target customers for these technologies have invested in expensive dispensers, high-throughput screening (HTS) systems, or other automation in the last several years and are hence reluctant to invest in a new system.

In addition, target laboratories have invested in equipment with high-throughput capabilities, such as electrophoresis apparati, chromatography, and polymerase chain reaction (PCR) systems. Moreover, many researchers hesitate to purchase biochip technologies since the price of the required capital equipment is too high.

Manufacturers need to offset this notion through marketing campaigns that emphasize the cost-saving benefits of using DNA microarrays, proteomics arrays, and microfluidics/lab-on-a-chip technologies. They should emphasize the ability of these technologies to decrease long-term costs and sample sizes, increase productivity, reproducibility, and improve efficiency. Market participants can further benefit by expanding into niche markets and developing flexible systems targeted at numerous applications.

Strategic Analysis of U.S. Biochips Markets is part of the Drug Discovery Technologies subscription, which also includes research in the following markets: strategic analysis of U.S. genomics, U.S. DNA sequencing technology, and U.S. life science mass spectrometry. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants. Interviews are available to the press.

Frost and Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost and Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Time Saving Benefits of Biochips Propels their Demand in the U.S. Biochips Markets

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Melina Trevino 
(210) 247-2440 melina.trevino[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Press Releases:

Frost & Sullivan Lauds SnooZeal’s Unique Electrical Stimulation Therapy for Sleep Apnea in the European Market
ZOLL Expands the Rescuer Experience at EMS Today
Traditional Mass Spectrometers Give Way to High-resolution Technologies Such as MALDI-TOF Finds Frost & Sullivan
AccuVein, Inc. Named A Best Place to Work in Medical Sales for Second Consecutive Year
Ansell Limited Acquires Cleanroom and Healthcare Consumables Manufacturer Nitritex Limited
ZOLL to Showcase Expanded Portfolio of Advanced Resuscitation and Acute Critical Care Technologies at Arab Health 2017
Frost & Sullivan Awards Ansell for Entrenching itself in the Hand Protection Market with its Visionary Products and Technologies
ZOLL RescueNet ePCR Achieves Latest National Compliance Standard
Eye Tech Care Wins Top Honours from Frost & Sullivan for Developing the EyeOP1, the Only Computer-assisted System for Glaucoma Therapy
Frost & Sullivan Recognizes Nuvectra’s Pioneering Spinal Cord Stimulation Product for Chronic Pain Management

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  NAKIVO, Inc.

Visit  BizJobs.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today